Medical device containing a multi-ply knit fabric

Patent metadata

Field	Value
Publication number	US-2020107962-A1
Application number	US-201916580417-A
Country	US
Kind code	A1
Filing date	Sep 24, 2019
Priority date	Oct 4, 2018
Publication date	Apr 9, 2020
Grant date	—

Abstract

A medical device comprising a device that covers at least a portion of a patient's skin and has an inner surface designed to be in contact with the patient's skin. It contains a multi-ply knit fabric that contains a first knit ply and a second knit ply. The first knit ply contains a plurality of first yarns and forms the upper surface of the fabric. The second knit ply contains a plurality of polytetrafluoroethylene (PTFE) yarns which forms the lower surface of the fabric. The first and second ply are integrated through combined portions formed by interlacing first yarns among the PTFE yarns, interlacing PTFE yarns among the first yarns, and interlacing a plurality of third yarns among the first and the PTFE yarns. The multi-ply knit fabric also contains a composition comprising at least one silver ion-containing compound on at least the upper surface of the multi-ply knit fabric.

First claim

What is claimed is:

1 . A medical device comprising a device that covers at least a portion of a patient's skin, wherein the device has an inner surface and an outer surface, wherein the inner surface is designed to be in contact with the patient's skin, wherein the inner surface of the device comprises a multi-ply knit fabric having an upper and lower surface and a length and width, wherein the fabric comprises:
a first knit ply comprising a plurality of first yarns, wherein the first knit ply forms the upper surface of the fabric; a second knit ply comprising a plurality of polytetrafluoroethylene (PTFE) yarns, wherein the PTFE yarns have a density of about 2 to 2.3 g/cm 3 , a transmission in the IR region of 8-10 μm at least about 40%, and a thermal conductivity of at least about 0.2 W/(m·K), wherein the second knit ply forms the lower surface of the fabric; wherein the first ply and the second ply integrated through combined portions formed by at least one method selected from the group consisting of interlacing first yarns among the PTFE yarns of the second knit ply, interlacing PTFE yarns among the first yarns of the first knit ply, and interlacing a plurality of third yarns among the first yarns of the first knit ply and the PTFE yarns of the second knit ply; and, a composition comprising at least one silver ion-containing compound on at least the upper surface of the multi-ply knit fabric; wherein the multi-ply knit fabric is positioned such that the lower surface of the multi-layer knit fabric is adjacent the patient's skin.

2 . The medical device of claim 1 , wherein the PTFE yarns have a generally rectangular cross-sectional shape.

3 . The medical device of claim 1 , wherein the fabric comprises less than about 75% by weight PTFE yarns.

4 . The medical device of claim 1 , wherein the fabric comprises less than about 50% by weight PTFE yarns.

5 . The medical device of claim 1 , wherein the second knit ply comprises at least about 90% by weight PTFE yarns.

6 . The medical device of claim 1 , wherein the PTFE yarns comprise a density of about 2.15 to 2.25 g/cm 3 .

7 . The medical device of claim 1 , wherein the PTFE yarns comprise a transmission in the IR region of 8-10 μm at least about 60%.

8 . The medical device of claim 1 , wherein the PTFE yarns comprise a thermal conductivity of at least about 0.23 W/(m·K).

9 . The medical device of claim 1 , wherein the rectangular cross-sectional shape of the PTFE yarns has a width to height ratio of between about 20:1 to 100:1.

10 . The medical device of claim 1 , wherein the lower surface of the fabric has a surface roughness of less than about 500 μm.

11 . The medical device of claim 1 , wherein the multi-ply knit fabric comprises a composition on at least the upper surface of the multi-ply knit fabric, wherein the composition comprises at least one silver ion-containing compound.

12 . The medical device of claim 11 , wherein the at least one silver ion-containing compound is selected from the group consisting of silver ion exchange materials, silver particles, silver salts, silver glass, and mixtures thereof.

13 . The medical device of claim 12 , wherein the silver ion exchange material is selected from the group consisting of silver zirconium phosphate, silver calcium phosphate, silver zeolite, and mixtures thereof.

14 . The medical device of claim 12 , wherein the silver ion exchange material is silver zirconium phosphate.

15 . The medical device of claim 1 , wherein the composition further comprises a binding agent selected from the group consisting of polyurethane binders, acrylic binders, and mixtures thereof.

16 . The medical device of 15 , wherein the binding agent is a polyurethane-based material.

17 . The medical device of claim 1 , wherein the medical device comprises a cast.

18 . The medical device of claim 1 , wherein the medical device comprises a compression device.

19 . The medical device of claim 1 , wherein the medical device comprises a decompression device.

Assignees

• Milliken & Co

Inventors

• Mondal Rajib
• Wiles Thomas C
• Valenta Petr
• Rogers James A
• Michaels Emily W
• Miller Robert D

Classifications

• A61L27/18

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

• A61L27/16

  obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

• D10B2321/042

  polymers of fluorinated hydrocarbons, e.g. polytetrafluoroethene [PTFE] · CPC title

• A61F13/04

  Plaster of Paris bandages; Other stiffening bandages (A61F13/06 - A61F13/15 take precedence; orthopaedic casts made from stiffening bandages A61F5/01) · CPC title

• D04B21/20

  specially adapted for knitting articles of particular configuration · CPC title